| Results summary | View all lists in GO:BiolProc | View all genes in C07AA.profile.ud50 |
|
A biological process whose specific outcome is the progression of an integrated living unit: a cell, tissue, organ, or organism over time from an initial condition to a later condition. enrichment: 1.43-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 213993_AT | SPON1 | D | C | spondin 1, extracellular matrix protein | |||||||||
| 210299_S_AT | FHL1 | D | four and a half LIM domains 1 | ||||||||||
| 205396_AT | SMAD3 | G | D | X | R | S | SMAD family member 3 | ||||||
| 217040_X_AT | SOX15 | D | R | SRY (sex determining region Y)-box 15 | |||||||||
| 210002_AT | GATA6 | D | R | GATA binding protein 6 | |||||||||
| 200680_X_AT | HMGB1 | G | X | R | S | high-mobility group box 1 | |||||||
| 212516_AT | CENTD2 | S | centaurin, delta 2 | ||||||||||
| 210865_AT | FASLG | G | D | X | C | S | Fas ligand (TNF superfamily, member 6) | ||||||
| 205558_AT | TRAF6 | G | X | P | S | TNF receptor-associated factor 6 | |||||||
| 205116_AT | LAMA2 | D | C | laminin, alpha 2 (merosin, congenital muscular dystrophy) | |||||||||
| 204878_S_AT | TAOK2 | G | T | X | P | C | S | TAO kinase 2 | |||||
| 204179_AT | MB | T | D | X | myoglobin | ||||||||
| 204501_AT | NOV | nephroblastoma overexpressed gene | |||||||||||
| 205039_S_AT | IKZF1 | D | R | IKAROS family zinc finger 1 (Ikaros) | |||||||||
| 209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 201069_AT | MMP2 | D | E | P | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | ||||||||
| 216178_X_AT | ITGB1 | D | C | S | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | ||||||||
| 209812_X_AT | CASP2 | G | P | S | caspase 2, apoptosis-related cysteine peptidase (neural precursor cell expressed, developmentally down-regulated 2) | ||||||||
| 207643_S_AT | TNFRSF1A | G | X | E | R | S | tumor necrosis factor receptor superfamily, member 1A | ||||||
| 211143_X_AT | NR4A1 | G | R | S | nuclear receptor subfamily 4, group A, member 1 | ||||||||
| 204421_S_AT | FGF2 | G | D | P | C | S | fibroblast growth factor 2 (basic) | ||||||
| 217607_X_AT | EIF4G2 | P | eukaryotic translation initiation factor 4 gamma, 2 | ||||||||||
| 211097_S_AT | PBX2 | D | R | pre-B-cell leukemia homeobox 2 | |||||||||
| 203706_S_AT | FZD7 | D | S | frizzled homolog 7 (Drosophila) | |||||||||
| 42361_G_AT | CCHCR1 | T | D | coiled-coil alpha-helical rod protein 1 | |||||||||
| 206926_S_AT | IL11 | G | D | X | C | interleukin 11 | |||||||
| 205780_AT | BIK | G | S | BCL2-interacting killer (apoptosis-inducing) | |||||||||
| 221691_X_AT | NPM1 | G | T | X | R | S | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | ||||||
| 221979_AT | TOPORS | G | X | P | R | topoisomerase I binding, arginine/serine-rich | |||||||
| 211943_X_AT | TPT1 | G | T | tumor protein, translationally-controlled 1 | |||||||||